Algenex

acquiredunknown
unknown
Stage
2003
Founded
2
Investors

About

Algenex is a biotech company developing proprietary Baculovirus vector expression systems in insect cells to produce recombinant proteins for animal health, human health, diagnostics, and biocomponents.

Explore Algenex's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.